Conference Coverage
Conference Coverage
AI-Assisted Colonoscopy Linked to Higher Rate of Benign Lesion Removal
The findings indicate that full adoption of AIAC could result in about 600,000 more colonoscopies in which only benign, nonadenomatous lesions are...
Conference Coverage
Short-Course Vasoconstrictors After EVL: Time for a New Standard of Care?
“This approach would allow earlier discharge from the hospital and reduce the risk of adverse events,” said Dr. Sushrut Ingawale.
Latest News
Study Finds Link to Increased Risk for Bulimia, Binge Eating and HS
“Clinicians should actively screen for eating disorders,” particularly bulimia nervosa and binge eating disorder, in patients with HS,” the lead...
Conference Coverage
Guselkumab Efficacy in Crohn’s Disease Unaffected by Prior Biologic Use
Almost all patients in the biologic-inadequate response group had previously received at least one anti–tumor necrosis factor agent, and around 15...
Conference Coverage
Patients With IBD More Likely to Develop, or Have Prior, T1D
Patients with IBD had a moderately increased risk for T1D and higher odds of having prior T1D than the general population.
Latest News
Effects of Bimekizumab Durable for HS Through One Year
“Efficacy and health-related quality-of-life outcomes were maintained through 2 years of treatment,” according to the study presenter.
Conference Coverage
Coming Soon: A New Disease Definition, ‘Clinical Obesity’
“I think it’ll help explain and move medicine as a whole in a direction to a greater understanding of obesity actually being a disease, how to...
Latest News
Anaphylaxis Treatment Uncertainty Persists for Patients and Professionals
Many patients and families struggle to recognize and manage severe allergic reactions effectively.
Conference Coverage
ATA: Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Researchers compared medical records of adults with type 2 diabetes and moderate cardiovascular risk who were new users of GLP-1 receptor agonists...
Latest News
Social Adversity Increases Mortality Risk in Patients With Pulmonary Hypertension
HIV+ patients with HF, PH, and social adversity had a sevenfold increase in all-cause mortality.
Latest News
Metformin May Reduce Long COVID in Non-Diabetic Population
Other trials have highlighted the anti-inflammatory and antiviral properties of metformin.